Consequences of underexpansion of a percutaneous aortic valve bioprosthesis.
Transcatheter aortic valve implantation has been shown to be an effective and reproducible therapy for severe aortic valve stenosis. Device performance and short-term outcomes of well-deployed prostheses have been extensively investigated and discussed; however, these endpoints have not yet been reported in cases characterized by suboptimal expansion. We describe a case of CoreValve self-expanding prosthesis underexpansion, reporting data on prosthesis performance and short-term clinical outcome.
Ussia
Gian Paolo
GP
Invasive Cardiology, Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy. gpussia@hotmail.com
Barbanti
Marco
M
Tamburino
Corrado
C
D000369:Aged, 80 and over; D001024:Aortic Valve Stenosis / Q000473:pathology* / Q000601:surgery*; D002114:Calcinosis / Q000473:pathology*; D006328:Cardiac Catheterization; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006801:Humans; D008297:Male; D011475:Prosthesis Failure; D011788:Quality of Life; D020127:Recovery of Function; D012720:Severity of Illness Index; D016896:Treatment Outcome